Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.89% Nasdaq Up1.26%

Sanofi (SNY)

-NYSE

55.00 Up 2.13(4.03%) 4:02PM EDT|After Hours : 54.98 Down 0.02 (0.04%) 6:18PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 47,406,000   45,511,000   45,661,000  
Cost of Revenue14,658,000  14,153,000  12,608,000  
Gross Profit 32,748,000   31,358,000   33,053,000  
Operating Expenses
Research Development6,489,000  6,245,000  6,100,000  
Selling General and Administrative11,907,000  11,056,000  10,829,000  
Non Recurring1,659,000  2,314,000  2,623,000  
Others4,339,000  4,302,000  4,734,000  
Total Operating Expenses24,394,000  23,917,000  24,286,000  
Operating Income or Loss 8,355,000   7,440,000   8,767,000  
Income from Continuing Operations
Total Other Income/Expenses Net123,000  182,000  142,000  
Earnings Before Interest And Taxes8,477,000  7,622,000  8,909,000  
Interest Expense729,000  717,000  628,000  
Income Before Tax7,748,000  6,905,000  8,281,000  
Income Tax Expense1,495,000  591,000  1,918,000  
Minority Interest(223,000)(313,000)(341,000)
Net Income From Continuing Ops6,549,000  7,390,000  7,334,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 6,549,000   7,390,000   7,334,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 6,549,000   7,390,000   7,334,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.